Development Level

Tbio 8 | 10,625
Tchem 4 | 1,890
Tclin 1 | 602

IMPC Phenotype

preweaning lethality, complete... 3 | 633
embryonic lethality prior to o... 2 | 148
embryonic lethality prior to t... 2 | 187
abnormal embryo size 1 | 112
abnormal forebrain development 1 | 18
abnormal hindbrain development 1 | 24
abnormal midbrain development 1 | 22
abnormal neural tube closure 1 | 37
abnormal spinal cord morpholog... 1 | 8
decreased circulating creatini... 1 | 31
decreased circulating insulin ... 1 | 75
decreased lean body mass 1 | 195
decreased prepulse inhibition 1 | 52
decreased total body fat amoun... 1 | 186
hypoactivity 1 | 89
increased circulating HDL chol... 1 | 63
increased circulating choleste... 1 | 53
increased erythrocyte cell num... 1 | 26
increased lean body mass 1 | 107
increased or absent threshold ... 1 | 128
increased total body fat amoun... 1 | 57

Disease

Cancer 9 | 2,346
osteosarcoma 9 | 7,933
ovarian cancer 8 | 8,491
glioblastoma 6 | 5,572
lung cancer 6 | 4,473
medulloblastoma, large-cell 5 | 6,234
pancreatic cancer 5 | 2,300
psoriasis 5 | 6,685
tuberculosis 5 | 1,563
ulcerative colitis 5 | 2,087
Breast cancer 4 | 3,098
atypical teratoid / rhabdoid tumor 4 | 4,369
interstitial cystitis 4 | 2,299
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,289
malignant mesothelioma 4 | 3,163
posterior fossa group A ependymoma 4 | 1,511
Barrett's esophagus 3 | 185
Kidney disease 3 | 397
Lung disease 3 | 136
Prostatic Neoplasms 3 | 471
Toxic encephalopathy 3 | 131
Vascular disease 3 | 281
adult high grade glioma 3 | 2,148
diabetes mellitus 3 | 1,663
hepatocellular carcinoma 3 | 550
invasive ductal carcinoma 3 | 2,950
lung adenocarcinoma 3 | 2,714
mucosa-associated lymphoid tissue lymphoma 3 | 480
nasopharyngeal carcinoma 3 | 1,056
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,795
primary pancreatic ductal adenocarcinoma 3 | 1,271
subependymal giant cell astrocytoma 3 | 2,287
Amyotrophic Lateral Sclerosis 2 | 432
Autistic Disorder 2 | 320
Carcinoma 2 | 2,147
Colonic Neoplasms 2 | 126
Colorectal Neoplasms 2 | 217
Conjunctivitis 2 | 18
Coronary artery disease 2 | 240
Crohn's disease 2 | 304
Endometriosis 2 | 535
Hemangioma 2 | 35
Herpes simplex 2 | 19
Hypersensitivity reaction type II disease 2 | 235
Hypertension 2 | 293
Hypertensive disease 2 | 193
Inflammation 2 | 109
Liver carcinoma 2 | 217
Lung Neoplasms 2 | 171
Mammary Neoplasms 2 | 410
Multiple myeloma 2 | 1,327
Neoplasm Metastasis 2 | 138
Polycystic Ovary Syndrome 2 | 334
Renal Cell Carcinoma 2 | 199
Rheumatoid Arthritis 2 | 1,170
Squamous cell carcinoma of esophagus 2 | 82
Thrombocytopenia 2 | 105
acute myeloid leukemia 2 | 785
astrocytoma 2 | 1,493
autosomal dominant Emery-Dreifuss muscular dystrophy 2 | 499
cutaneous lupus erythematosus 2 | 1,056
cystic fibrosis 2 | 1,670
ductal carcinoma in situ 2 | 1,745
esophageal adenocarcinoma 2 | 737
juvenile dermatomyositis 2 | 1,189
lung carcinoma 2 | 2,844
non-small cell lung cancer 2 | 2,798
oligodendroglioma 2 | 2,849
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
pituitary cancer 2 | 1,972
posterior fossa group B ependymoma 2 | 1,530
primary Sjogren syndrome 2 | 788
ADRENOCORTICAL CARCINOMA, HEREDITARY 1 | 1
Adenocarcinoma Of Esophagus 1 | 14
Adenocarcinoma, Clear Cell 1 | 2
Adrenocortical Carcinoma, Pediatric 1 | 1
Anaplastic thyroid carcinoma 1 | 2
BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7 1 | 1
Breast adenocarcinoma 1 | 8
Carcinoma, Small Cell 1 | 8
Central Nervous System Neoplasms 1 | 1
Cervix carcinoma 1 | 6
Choroid Plexus Carcinoma 1 | 4
Choroid Plexus Papilloma 1 | 10
Chromosome 17 deletion 1 | 2
GLIOMA SUSCEPTIBILITY 1 1 | 5
Genitourinary Neoplasms 1 | 3
Hereditary Breast and Ovarian Cancer Syndrome 1 | 14
LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3 1 | 20
LI-FRAUMENI SYNDROME 1 1 | 2
Leukemia, Megakaryoblastic, of Down Syndrome 1 | 9
Li-Fraumeni Syndrome 2 1 | 2
Li-Fraumeni-Like Syndrome 1 | 1
Mediastinal Germ Cell Tumor 1 | 2
Small cell carcinoma of lung 1 | 45
Stomach cancer 1 | 18
T-Cell Lymphoma 1 | 11
Thymoma 1 | 16
Urologic Neoplasms 1 | 7

Tissue

Blood and immune system 13 | 17,994
Cardiovascular System 13 | 17,957
Digestive Tract 13 | 18,472
Endocrine System 13 | 18,511
Female tissues 13 | 18,646
Liver and Pancreas 13 | 18,135
Male tissues 13 | 17,968
Nervous System 13 | 18,560
Respiratory system 13 | 17,483
Skin and soft tissues 13 | 18,114
Urinary Tract 13 | 18,443

Target Family

Non-IDG 8 | 11,969
Enzyme 2 | 4,146
Kinase 2 | 634
Transcription Factor 1 | 1,400

Grant Application

5P01CA071933-15 13 | 13
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Prominin-1 PROM1 Tbio Non-IDG -3.27144 1922.5 226
Tumor necrosis factor receptor superfamily member 14 TNFRSF14 Tbio Non-IDG -2.37320 264.6 453
Plasminogen PLG Tclin Enzyme -3.95078 5412.9 775
Dual specificity mitogen-activated protein kinase kinase 7 MAP2K7 Tchem Kinase -3.63010 3454.0 459
Guanine nucleotide-binding protein subunit alpha-12 GNA12 Tbio Non-IDG -0.95871 8.08 143
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.11585 140.7 401
Urokinase plasminogen activator surface receptor PLAUR Tchem Enzyme -2.95578 1004.9 275
Absent in melanoma 1 protein AIM1 Tbio Non-IDG -1.08081 11.8 9
Nectin-1 NECTIN1 Tbio Non-IDG -2.53790 361.4 211
Interferon-induced, double-stranded RNA-activated protein kinase EIF2AK2 Tbio Kinase -1.93631 85.7 805